gloucester healthcare partnership limited
gloucester healthcare partnership limited Company Information
Company Number
04341298
Website
semperian.co.ukRegistered Address
part first floor, 1 grenfell road, maidenhead, berkshire, SL6 1HN
Industry
Other financial service activities, except insurance and pension funding, (not including security dealing on own account and factoring) n.e.c.
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
healthcare providers gloucester ltd 100%
gloucester healthcare partnership limited Estimated Valuation
The estimated valuation range for gloucester healthcare partnership limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £4.4m to £8.3m
gloucester healthcare partnership limited Estimated Valuation
The estimated valuation range for gloucester healthcare partnership limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £4.4m to £8.3m
gloucester healthcare partnership limited Estimated Valuation
The estimated valuation range for gloucester healthcare partnership limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £4.4m to £8.3m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Gloucester Healthcare Partnership Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Gloucester Healthcare Partnership Limited Overview
Gloucester Healthcare Partnership Limited is a live company located in maidenhead, SL6 1HN with a Companies House number of 04341298. It operates in the financial intermediation not elsewhere classified sector, SIC Code 64999. Founded in December 2001, it's largest shareholder is healthcare providers gloucester ltd with a 100% stake. Gloucester Healthcare Partnership Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gloucester Healthcare Partnership Limited Health Check
Pomanda's financial health check has awarded Gloucester Healthcare Partnership Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £3.8m, make it in line with the average company (£4.6m)
£3.8m - Gloucester Healthcare Partnership Limited
£4.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (3.2%)
-1% - Gloucester Healthcare Partnership Limited
3.2% - Industry AVG
Production
with a gross margin of 38.7%, this company has a higher cost of product (61.4%)
38.7% - Gloucester Healthcare Partnership Limited
61.4% - Industry AVG
Profitability
an operating margin of 32.8% make it more profitable than the average company (10.8%)
32.8% - Gloucester Healthcare Partnership Limited
10.8% - Industry AVG
Employees
with 17 employees, this is similar to the industry average (15)
- Gloucester Healthcare Partnership Limited
15 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Gloucester Healthcare Partnership Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £221.6k, this is equally as efficient (£228.5k)
- Gloucester Healthcare Partnership Limited
£228.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Gloucester Healthcare Partnership Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 14 days, this is quicker than average (37 days)
14 days - Gloucester Healthcare Partnership Limited
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Gloucester Healthcare Partnership Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 57 weeks, this is more cash available to meet short term requirements (39 weeks)
57 weeks - Gloucester Healthcare Partnership Limited
39 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 88.7%, this is a higher level of debt than the average (58.6%)
88.7% - Gloucester Healthcare Partnership Limited
58.6% - Industry AVG
gloucester healthcare partnership limited Credit Report and Business Information
Gloucester Healthcare Partnership Limited Competitor Analysis
Perform a competitor analysis for gloucester healthcare partnership limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
gloucester healthcare partnership limited Ownership
GLOUCESTER HEALTHCARE PARTNERSHIP LIMITED group structure
Gloucester Healthcare Partnership Limited has no subsidiary companies.
Ultimate parent company
1 parent
GLOUCESTER HEALTHCARE PARTNERSHIP LIMITED
04341298
gloucester healthcare partnership limited directors
Gloucester Healthcare Partnership Limited currently has 4 directors. The longest serving directors include Mr Neil Rae (Jun 2009) and Mr Ian Tayler (Oct 2013).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Neil Rae | United Kingdom | 52 years | Jun 2009 | - | Director |
| Mr Ian Tayler | England | 48 years | Oct 2013 | - | Director |
| Mr Albert Naafs | 59 years | May 2015 | - | Director | |
| Mr Richard Little | England | 44 years | Jun 2016 | - | Director |
GLOUCESTER HEALTHCARE PARTNERSHIP LIMITED financials
Gloucester Healthcare Partnership Limited's latest turnover from December 2022 is £3.8 million and the company has net assets of £3.8 million. According to their latest financial statements, we estimate that Gloucester Healthcare Partnership Limited has 17 employees and maintains cash reserves of £5.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,768,000 | 4,200,000 | 3,774,000 | 3,927,000 | 3,582,000 | 2,944,000 | 2,578,000 | 2,734,000 | 4,418,000 | 3,530,000 | 1,997,000 | 2,869,000 | 1,791,000 | 1,225,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost Of Sales | 2,310,000 | 3,016,000 | 2,726,000 | 2,736,000 | 2,465,000 | 2,037,000 | 1,741,000 | 1,797,000 | ||||||
| Gross Profit | 1,458,000 | 1,184,000 | 1,048,000 | 1,191,000 | 1,117,000 | 907,000 | 837,000 | 937,000 | ||||||
| Admin Expenses | 221,000 | 218,000 | 202,000 | 201,000 | 180,000 | 165,000 | 169,000 | 167,000 | ||||||
| Operating Profit | 1,237,000 | 966,000 | 846,000 | 990,000 | 937,000 | 742,000 | 668,000 | 770,000 | 1,385,000 | 935,000 | 544,000 | 1,134,000 | 471,000 | 53,000 |
| Interest Payable | 1,537,000 | 1,457,000 | 1,500,000 | 1,537,000 | 1,598,000 | 1,632,000 | 1,674,000 | 1,710,000 | 1,753,000 | 1,729,000 | 1,802,000 | 1,880,000 | 1,880,000 | 1,948,000 |
| Interest Receivable | 1,576,000 | 1,630,000 | 1,724,000 | 1,806,000 | 1,864,000 | 1,935,000 | 1,964,000 | 2,016,000 | 2,068,000 | 2,115,000 | 2,183,000 | 2,245,000 | 2,286,000 | 2,323,000 |
| Pre-Tax Profit | 1,276,000 | 1,139,000 | 1,070,000 | 1,259,000 | 1,203,000 | 1,045,000 | 958,000 | 1,076,000 | 1,700,000 | 1,321,000 | 925,000 | 1,499,000 | 877,000 | 428,000 |
| Tax | 309,000 | -1,486,000 | -668,000 | -281,000 | -267,000 | -287,000 | -32,000 | 12,000 | -409,000 | -60,000 | -112,000 | -324,000 | -249,000 | -144,000 |
| Profit After Tax | 1,585,000 | -347,000 | 402,000 | 978,000 | 936,000 | 758,000 | 926,000 | 1,088,000 | 1,291,000 | 1,261,000 | 813,000 | 1,175,000 | 628,000 | 284,000 |
| Dividends Paid | 1,101,000 | 1,222,000 | 1,407,000 | 384,000 | 545,000 | 213,000 | 567,000 | 97,000 | 687,000 | 772,000 | 778,000 | 848,000 | 77,000 | 0 |
| Retained Profit | 484,000 | -1,569,000 | -1,005,000 | 594,000 | 391,000 | 545,000 | 359,000 | 991,000 | 604,000 | 489,000 | 35,000 | 327,000 | 551,000 | 284,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Number Of Employees | ||||||||||||||
| EBITDA* | 1,237,000 | 966,000 | 846,000 | 990,000 | 937,000 | 742,000 | 668,000 | 770,000 | 1,385,000 | 935,000 | 544,000 | 1,134,000 | 471,000 | 53,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 25,387,000 | 27,889,000 | 28,893,000 | 29,364,000 | 29,604,000 | 30,133,000 | 31,011,000 | 31,730,000 | 32,693,000 | 29,774,000 | 30,899,000 | 30,826,000 | 31,460,000 | 32,053,000 |
| Total Fixed Assets | 25,387,000 | 27,889,000 | 28,893,000 | 29,364,000 | 29,604,000 | 30,133,000 | 31,011,000 | 31,730,000 | 32,693,000 | 29,774,000 | 30,899,000 | 30,826,000 | 31,460,000 | 32,053,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 5,000 | 1,192,000 | 593,000 | 571,000 | 582,000 | 544,000 | 1,555,000 | 528,000 | 11,000 | 107,000 | 1,129,000 | 20,000 | 406,000 |
| Group Debtors | 0 | 7,000 | 7,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,857,000 | 1,267,000 | 1,188,000 | 1,104,000 | 1,032,000 | 962,000 | 941,000 | 931,000 | 927,000 | 747,000 | 45,000 | 44,000 | 636,000 | 595,000 |
| Cash | 5,635,000 | 6,681,000 | 5,116,000 | 5,029,000 | 4,990,000 | 4,701,000 | 3,671,000 | 1,980,000 | 2,075,000 | 667,000 | 3,957,000 | 838,000 | 347,000 | 1,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,962,000 | 0 | 3,282,000 | 4,100,000 | 3,305,000 |
| total current assets | 8,492,000 | 7,960,000 | 7,503,000 | 6,726,000 | 6,593,000 | 6,245,000 | 5,156,000 | 4,466,000 | 3,530,000 | 4,387,000 | 4,109,000 | 5,293,000 | 5,103,000 | 4,307,000 |
| total assets | 33,879,000 | 35,849,000 | 36,396,000 | 36,090,000 | 36,197,000 | 36,378,000 | 36,167,000 | 36,196,000 | 36,223,000 | 34,161,000 | 35,008,000 | 36,119,000 | 36,563,000 | 36,360,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 1,258,000 | 1,258,000 | 605,000 | 573,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 1,684,000 | 1,337,000 | 1,176,000 | 1,059,000 | 0 | 0 | 0 | 0 | 647,000 | 1,407,000 | 1,445,000 | 1,324,000 | 1,102,000 | 1,027,000 |
| Trade Creditors | 91,000 | 94,000 | 101,000 | 62,000 | 110,000 | 107,000 | 57,000 | 0 | 0 | 0 | 0 | 182,000 | 64,000 | 158,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28,000 | 0 | 63,000 | 85,000 | 98,000 |
| other short term finances | 0 | 0 | 0 | 29,000 | 29,000 | 26,000 | 0 | 0 | 0 | 0 | 31,000 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 3,350,000 | 1,979,000 | 1,317,000 | 189,000 | 366,000 | 284,000 | 223,000 | 267,000 | 200,000 | 316,000 | 289,000 | 721,000 | 594,000 | 339,000 |
| total current liabilities | 5,125,000 | 3,410,000 | 2,594,000 | 1,339,000 | 1,763,000 | 1,675,000 | 885,000 | 840,000 | 847,000 | 1,751,000 | 1,765,000 | 2,290,000 | 1,845,000 | 1,622,000 |
| loans | 20,205,000 | 21,471,000 | 22,298,000 | 22,930,000 | 23,462,000 | 24,158,000 | 25,395,000 | 34,286,000 | 26,529,000 | 26,895,000 | 27,733,000 | 28,600,000 | 29,325,000 | 29,967,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 222,000 | 244,000 | 266,000 | 287,000 | 309,000 | 331,000 | 353,000 | 375,000 | 433,000 | 497,000 | 1,041,000 | 714,000 | 1,529,000 | 1,707,000 |
| other liabilities | 1,440,000 | 5,465,000 | 7,806,000 | 7,442,000 | 7,463,000 | 8,688,000 | 9,587,000 | 0 | 9,394,000 | 0 | 0 | 0 | 0 | 0 |
| provisions | 3,049,000 | 4,924,000 | 3,752,000 | 3,261,000 | 2,980,000 | 2,714,000 | 2,426,000 | 2,395,000 | 2,407,000 | 1,896,000 | 1,836,000 | 1,724,000 | 1,400,000 | 1,151,000 |
| total long term liabilities | 24,916,000 | 32,104,000 | 34,122,000 | 33,920,000 | 34,214,000 | 35,891,000 | 37,761,000 | 37,056,000 | 38,763,000 | 29,288,000 | 30,610,000 | 31,038,000 | 32,254,000 | 32,825,000 |
| total liabilities | 30,041,000 | 35,514,000 | 36,716,000 | 35,259,000 | 35,977,000 | 37,566,000 | 38,646,000 | 37,896,000 | 39,610,000 | 31,039,000 | 32,375,000 | 33,328,000 | 34,099,000 | 34,447,000 |
| net assets | 3,838,000 | 335,000 | -320,000 | 831,000 | 220,000 | -1,188,000 | -2,479,000 | -1,700,000 | -3,387,000 | 3,122,000 | 2,633,000 | 2,791,000 | 2,464,000 | 1,913,000 |
| total shareholders funds | 3,838,000 | 335,000 | -320,000 | 831,000 | 220,000 | -1,188,000 | -2,479,000 | -1,700,000 | -3,387,000 | 3,122,000 | 2,633,000 | 2,791,000 | 2,464,000 | 1,913,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 1,237,000 | 966,000 | 846,000 | 990,000 | 937,000 | 742,000 | 668,000 | 770,000 | 1,385,000 | 935,000 | 544,000 | 1,134,000 | 471,000 | 53,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 309,000 | -1,486,000 | -668,000 | -281,000 | -267,000 | -287,000 | -32,000 | 12,000 | -409,000 | -60,000 | -112,000 | -324,000 | -249,000 | -144,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -924,000 | -2,112,000 | 219,000 | -146,000 | -470,000 | -819,000 | -1,720,000 | 68,000 | 3,616,000 | -519,000 | -948,000 | -117,000 | -938,000 | 33,054,000 |
| Creditors | -3,000 | -7,000 | 39,000 | -48,000 | 3,000 | 50,000 | 57,000 | 0 | 0 | 0 | -182,000 | 118,000 | -94,000 | 158,000 |
| Accruals and Deferred Income | 1,349,000 | 640,000 | 1,107,000 | -199,000 | 60,000 | 39,000 | -66,000 | 9,000 | -180,000 | -517,000 | -105,000 | -688,000 | 77,000 | 2,046,000 |
| Deferred Taxes & Provisions | -1,875,000 | 1,172,000 | 491,000 | 281,000 | 266,000 | 288,000 | 31,000 | -12,000 | 511,000 | 60,000 | 112,000 | 324,000 | 249,000 | 1,151,000 |
| Cash flow from operations | 1,941,000 | 3,397,000 | 1,596,000 | 889,000 | 1,469,000 | 1,651,000 | 2,378,000 | 711,000 | -2,309,000 | 937,000 | 1,205,000 | 681,000 | 1,392,000 | -29,790,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 347,000 | 161,000 | 117,000 | 1,059,000 | 0 | 0 | 0 | -647,000 | -760,000 | -38,000 | 121,000 | 222,000 | 75,000 | 1,027,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28,000 | 28,000 | -63,000 | -22,000 | -13,000 | 98,000 |
| Other Short Term Loans | 0 | 0 | -29,000 | 0 | 3,000 | 26,000 | 0 | 0 | 0 | -31,000 | 31,000 | 0 | 0 | 0 |
| Long term loans | -1,266,000 | -827,000 | -632,000 | -532,000 | -696,000 | -1,237,000 | -8,891,000 | 7,757,000 | -366,000 | -838,000 | -867,000 | -725,000 | -642,000 | 29,967,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -4,025,000 | -2,341,000 | 364,000 | -21,000 | -1,225,000 | -899,000 | 9,587,000 | -9,394,000 | 9,394,000 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 39,000 | 173,000 | 224,000 | 269,000 | 266,000 | 303,000 | 290,000 | 306,000 | 315,000 | 386,000 | 381,000 | 365,000 | 406,000 | 375,000 |
| cash flow from financing | -1,886,000 | -610,000 | -102,000 | 792,000 | -635,000 | -1,061,000 | -152,000 | -1,282,000 | 1,442,000 | -493,000 | -590,000 | -160,000 | -174,000 | 33,096,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -1,046,000 | 1,565,000 | 87,000 | 39,000 | 289,000 | 1,030,000 | 1,691,000 | -95,000 | 1,408,000 | -3,290,000 | 3,119,000 | 491,000 | 346,000 | 1,000 |
| overdraft | 0 | 0 | 0 | -1,258,000 | 0 | 653,000 | 32,000 | 573,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,046,000 | 1,565,000 | 87,000 | 1,297,000 | 289,000 | 377,000 | 1,659,000 | -668,000 | 1,408,000 | -3,290,000 | 3,119,000 | 491,000 | 346,000 | 1,000 |
P&L
December 2022turnover
3.8m
-10%
operating profit
1.2m
+28%
gross margin
38.7%
+37.26%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
3.8m
+10.46%
total assets
33.9m
-0.05%
cash
5.6m
-0.16%
net assets
Total assets minus all liabilities
gloucester healthcare partnership limited company details
company number
04341298
Type
Private limited with Share Capital
industry
64999 - Other financial service activities, except insurance and pension funding, (not including security dealing on own account and factoring) n.e.c.
incorporation date
December 2001
age
23
accounts
Small Company
ultimate parent company
previous names
N/A
incorporated
UK
address
part first floor, 1 grenfell road, maidenhead, berkshire, SL6 1HN
last accounts submitted
December 2022
gloucester healthcare partnership limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to gloucester healthcare partnership limited. Currently there are 1 open charges and 0 have been satisfied in the past.
gloucester healthcare partnership limited Companies House Filings - See Documents
| date | description | view/download |
|---|
